These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Haematological adverse effects associated with linezolid in patients with drug-resistant tuberculosis: an exploratory study.
    Author: Letswee G, Kamau H, Gaida R, Truter I.
    Journal: Int J Pharm Pract; 2019 Dec; 27(6):575-577. PubMed ID: 31058394.
    Abstract:
    OBJECTIVES: Identify the incidence of haematological adverse effects associated with linezolid. METHODS: Medical records of 27 hospitalised patients in South Africa with drug-resistant tuberculosis (DR-TB) and prescribed linezolid therapy were retrospectively reviewed. KEY FINDINGS: Approximately a quarter (n = 7) of patients experienced haematological adverse effects. These included anaemia (14.8%; n = 4), low haemoglobin (7.4%; n = 2) and macrocytosis (3.7%; n = 1). All patients who exhibited haematological adverse effects were living with HIV. CONCLUSION: The haematological effects of linezolid manifested in patients who were suffering from co-morbid HIV. Haematological monitoring should be done monthly in order to detect adverse effects timeously and intervene as appropriate.
    [Abstract] [Full Text] [Related] [New Search]